Synthesis of Poly(butylcyanoacrylate) Nanocapsules by Interfacial Polymerization in Miniemulsions for the Delivery of DNA Molecules

被引:40
作者
Musyanovych, Anna [1 ]
Landfester, Katharina [1 ]
机构
[1] Univ Ulm, Inst Organ Chem Macromol Chem & Organ Mat 3, D-89081 Ulm, Germany
来源
SURFACE AND INTERFACIAL FORCES - FROM FUNDAMENTALS TO APPLICATIONS | 2008年 / 134卷
关键词
Biodegradable; DNA encapsulation; Interfacial polymerization; Nanocapsule; Poly(butylcyanoacrylate);
D O I
10.1007/2882_2008_089
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Monodispersed biodegradable poly(n-butylcyanoacrylate) nanocapsules containing DNA molecules (790 base pairs) within an aqueous core were prepared by anionic polymerization of n-butylcyanoacrylate at the droplets interface in inverse miniemulsion. The aqueous droplets in the size range of 300-700 nm dispersed in the hydrophobic continuous phase were formulated using the miniemulsion technique that allows an easy control of the droplet size and size distribution. After polymerization, the capsules were transferred into an aqueous phase. The effect of several reaction parameters such as the amount of monomer, type of the non-ionic surfactant (i.e. Span(R)80 and Tween(R)80) and type of the continuous phase (i.e. Miglyol 812N and cyclohexane) on the shell thickness, capsule size, morphology, polymer molecular weight, and encapsulation efficiency of DNA was investigated. The obtained results indicated that the type of the continuous phase has the largest influence on the capsule average size and polydispersity, whereas the shell thickness and morphology were mainly dependent on the monomer concentration. The encapsulation efficiency of DNA was about 100%, regardless to the surfactant type. At least, about 15% of the total DNA amount was found to be in the form of free chains.
引用
收藏
页码:120 / 127
页数:8
相关论文
共 48 条
[1]   Physico-chemical characterization of insulin-loaded poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization [J].
Aboubakar, M ;
Puisieux, F ;
Couvreur, P ;
Vauthier, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 183 (01) :63-66
[2]  
Al Khouri F, 1986, INT J PHARMACEUT, V28, P125
[3]   IN-VITRO EXTENDED-RELEASE PROPERTIES OF DRUG-LOADED POLY(DL-LACTIC ACID) NANOPARTICLES PRODUCED BY A SALTING-OUT PROCEDURE [J].
ALLEMANN, E ;
LEROUX, JC ;
GURNY, R ;
DOELKER, E .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1732-1737
[4]   Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics [J].
Allémann, E ;
Leroux, JC ;
Gurny, R .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :171-189
[6]  
Bechthold N, 2000, MACROMOL SYMP, V151, P549, DOI 10.1002/1521-3900(200002)151:1<549::AID-MASY549>3.0.CO
[7]  
2-D
[8]   Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
AAPS PHARMSCITECH, 2005, 6 (04)
[9]   PREPARATION AND PURIFICATION OF POLYISOHEXYLCYANOACRYLATE NANOCAPSULES [J].
CHOUINARD, F ;
KAN, FWK ;
LEROUX, JC ;
FOUCHER, C ;
LENAERTS, V .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 72 (03) :211-217
[10]  
Conway BR, 1996, EUR J PHARM BIOPHARM, V42, P42